SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue

Two years after its spreading, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still responsible for more than 2000 deaths per day worldwide, despite vaccines and monoclonal antibody countermeasures. Therefore, there is a need to understand the immune–inflammatory pathways that p...

Full description

Bibliographic Details
Main Authors: Bianca Vezzani, Margherita Neri, Stefano D’Errico, Alberto Papi, Marco Contoli, Carlotta Giorgi
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/11/11/1390
_version_ 1797464233611362304
author Bianca Vezzani
Margherita Neri
Stefano D’Errico
Alberto Papi
Marco Contoli
Carlotta Giorgi
author_facet Bianca Vezzani
Margherita Neri
Stefano D’Errico
Alberto Papi
Marco Contoli
Carlotta Giorgi
author_sort Bianca Vezzani
collection DOAJ
description Two years after its spreading, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still responsible for more than 2000 deaths per day worldwide, despite vaccines and monoclonal antibody countermeasures. Therefore, there is a need to understand the immune–inflammatory pathways that prompt the manifestation of the disease to identify a novel potential target for pharmacological intervention. In this context, the characterization of the main players in the SARS-CoV-2-induced cytokine storm is mandatory. To date, the most characterized have been IL-6 and the class I and II interferons, while less is known about the proinflammatory cytokine IL-1β and class III interferons. Here, we report a preliminary study aimed at the characterization of the lung inflammatory context in COVID-19 patients, with a special focus on IFN-λ and IL-1β. By investigating IFN and inflammatory cytokine patterns by IHC in 10 deceased patients due to COVID-19 infection, compared to 10 control subjects, we reveal that while IFN-β production was increased in COVID-19 patients, IFN-λ was almost abolished. At the same time, the levels of IL-1β were dramatically improved, while IL-6 lung levels seem to be unaffected by the infection. Our findings highlight a central role of IL-1β in prompting lung inflammation after SARS-CoV-2 infection. Together, we show that IFN-λ is negatively affected by viral infection, supporting the idea that IFN-λ administration together with the pharmaceutical blockage of IL-1β represents a promising approach to revert the COVID-19-induced cytokine storm.
first_indexed 2024-03-09T18:05:20Z
format Article
id doaj.art-99c52d2764af4bc5a8af3c882bea3165
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-09T18:05:20Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-99c52d2764af4bc5a8af3c882bea31652023-11-24T09:34:57ZengMDPI AGPathogens2076-08172022-11-011111139010.3390/pathogens11111390SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung TissueBianca Vezzani0Margherita Neri1Stefano D’Errico2Alberto Papi3Marco Contoli4Carlotta Giorgi5Department of Medical Sciences, Section of Experimental Medicine, University of Ferrara, 44121 Ferrara, ItalyDepartment of Medical Sciences, Section of Public Health Medicine, University of Ferrara, 44121 Ferrara, ItalyDepartment of Medicine, Surgery and Health, University of Trieste, 34149 Trieste, ItalyRespiratory Medicine, Department of Translational Medicine, University of Ferrara, 44121 Ferrara, ItalyRespiratory Medicine, Department of Translational Medicine, University of Ferrara, 44121 Ferrara, ItalyDepartment of Medical Sciences, Section of Experimental Medicine, University of Ferrara, 44121 Ferrara, ItalyTwo years after its spreading, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still responsible for more than 2000 deaths per day worldwide, despite vaccines and monoclonal antibody countermeasures. Therefore, there is a need to understand the immune–inflammatory pathways that prompt the manifestation of the disease to identify a novel potential target for pharmacological intervention. In this context, the characterization of the main players in the SARS-CoV-2-induced cytokine storm is mandatory. To date, the most characterized have been IL-6 and the class I and II interferons, while less is known about the proinflammatory cytokine IL-1β and class III interferons. Here, we report a preliminary study aimed at the characterization of the lung inflammatory context in COVID-19 patients, with a special focus on IFN-λ and IL-1β. By investigating IFN and inflammatory cytokine patterns by IHC in 10 deceased patients due to COVID-19 infection, compared to 10 control subjects, we reveal that while IFN-β production was increased in COVID-19 patients, IFN-λ was almost abolished. At the same time, the levels of IL-1β were dramatically improved, while IL-6 lung levels seem to be unaffected by the infection. Our findings highlight a central role of IL-1β in prompting lung inflammation after SARS-CoV-2 infection. Together, we show that IFN-λ is negatively affected by viral infection, supporting the idea that IFN-λ administration together with the pharmaceutical blockage of IL-1β represents a promising approach to revert the COVID-19-induced cytokine storm.https://www.mdpi.com/2076-0817/11/11/1390SARS-CoV-2COVID-19IFN-λIL-1βIL-6lungs
spellingShingle Bianca Vezzani
Margherita Neri
Stefano D’Errico
Alberto Papi
Marco Contoli
Carlotta Giorgi
SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
Pathogens
SARS-CoV-2
COVID-19
IFN-λ
IL-1β
IL-6
lungs
title SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
title_full SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
title_fullStr SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
title_full_unstemmed SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
title_short SARS-CoV-2 Infection Prompts IL-1β-Mediated Inflammation and Reduces IFN-λ Expression in Human Lung Tissue
title_sort sars cov 2 infection prompts il 1β mediated inflammation and reduces ifn λ expression in human lung tissue
topic SARS-CoV-2
COVID-19
IFN-λ
IL-1β
IL-6
lungs
url https://www.mdpi.com/2076-0817/11/11/1390
work_keys_str_mv AT biancavezzani sarscov2infectionpromptsil1bmediatedinflammationandreducesifnlexpressioninhumanlungtissue
AT margheritaneri sarscov2infectionpromptsil1bmediatedinflammationandreducesifnlexpressioninhumanlungtissue
AT stefanoderrico sarscov2infectionpromptsil1bmediatedinflammationandreducesifnlexpressioninhumanlungtissue
AT albertopapi sarscov2infectionpromptsil1bmediatedinflammationandreducesifnlexpressioninhumanlungtissue
AT marcocontoli sarscov2infectionpromptsil1bmediatedinflammationandreducesifnlexpressioninhumanlungtissue
AT carlottagiorgi sarscov2infectionpromptsil1bmediatedinflammationandreducesifnlexpressioninhumanlungtissue